
Avoid the SpaceX IPO? ‘The juice has been squeezed from this orange’
SpaceX plans June IPO at about $1.75 trillion valuation, raising up to $75 billion, but analysts warn much of the value is already priced in,…

SpaceX plans June IPO at about $1.75 trillion valuation, raising up to $75 billion, but analysts warn much of the value is already priced in,…

According to Citi, profitability remains intact, with no immediate impact from commodity inflation. While management has guided for 6-9% cost inflation in FY27, it remains…

Disruptions in the Strait of Hormuz are threatening nearly a quarter of global oil flows, rattling markets and supply chains. Here are three scenarios that…
Anupam Tiwari, Head of Equity at Groww Mutual Fund, expects a strong current quarter with limited impact from oil shocks so far, but flags risks…

Alembic Pharma gets USFDA nod for generic Dapagliflozin tablets, equivalent to AstraZenecas Farxiga, gaining 180 day shared exclusivity in a $10.49 billion US market

Manish Sonthalia, CIO of Emkay Investment Managers highlights opportunities in financials, defence, power and IT, while advising caution on travel and real estate amid cost…

Brokerages expect Nykaa to deliver strong Q4 growth led by beauty and improving traction in fashion, with margins set to expand and losses narrowing, though…

Gautam Duggad, Head of Research, Director – Institutional Equities at Motilal Oswal Financial Services noted that sectoral trends have led to a broader earnings downgrade…

CreditAccess Grameen reported strong growth with higher disbursements, improvement in asset quality and branch expansion for the financial year 2026.

Brokerage firm Jefferies expects this railway stock to be a key beneficiary of the increasing passenger and metro coach demand. The stock has corrected significantly…